Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Tarabay

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Oncology|March 2, 2026
Weight variations during first-line systemic treatment of metastatic Non-Small Cell Lung Cancer: new paradigms from Real-World DataAlexandre Gravian, Arnaud Pagès, Anthony Tarabay, et al.
World Journal of Gastrointestinal Oncology|July 29, 2024
Role of molecular biology in the management of pancreatic cancerAlice Boileve, Cristina Smolenschi, Aurélien Lambert, et al.
Cancers|September 28, 2023
Targetable Molecular Alterations in the Treatment of Biliary Tract Cancers: An Overview of the Available TreatmentsMarine Valery, Damien Vasseur, Francesco Fachinetti, et al.
Biomedicines|September 28, 2023
Precision Medicine in Pancreatic Ductal Adenocarcinoma: The Impact of Targeted Therapies on Survival of Patients Harboring Actionable MutationsAnthony Tarabay, Alice Boileve, Cristina Smolenschi, et al.
Cancers|October 26, 2024
<i>KRAS</i>, a New Target for Precision Medicine in Colorectal Cancer?Alice Boilève, Cristina Smolenschi, Aurélien Lambert, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2025
Metastatic pancreatic adenocarcinoma: Real-world efficacy of first line treatmentMélanie Debiais, Anthony Tarabay, Sarah Blanchet-Deverly, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2026
Lung-only metastatic pancreatic cancer: Differences in patients 'characteristics, molecular profile and survivalAlice Boilève, Léa Mercier, Baptiste Bonnet, et al.
Future Oncology (London, England)|February 10, 2025
Predictive factors of FOLFIRINOX chemotherapy toxicity in pancreatic adenocarcinoma patientsRoland Eid, Anthony Tarabay, Pierre Decazes, et al.
International Journal of Cancer|August 15, 2024
Clinical and molecular features of early onset pancreatic adenocarcinomaMaxime Rémond, Cristina Smolenschi, Anthony Tarabay, et al.
European Journal of Cancer (Oxford, England : 1990)|November 9, 2025
Real-world immunotherapy outcomes in unresectable peritoneal mesothelioma: A French experienceCristina Smolenschi, Alice Boileve, Pauline Vaflard, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Oncology|March 2, 2026
Weight variations during first-line systemic treatment of metastatic Non-Small Cell Lung Cancer: new paradigms from Real-World DataAlexandre Gravian, Arnaud Pagès, Anthony Tarabay, et al.
World Journal of Gastrointestinal Oncology|July 29, 2024
Role of molecular biology in the management of pancreatic cancerAlice Boileve, Cristina Smolenschi, Aurélien Lambert, et al.
Cancers|September 28, 2023
Targetable Molecular Alterations in the Treatment of Biliary Tract Cancers: An Overview of the Available TreatmentsMarine Valery, Damien Vasseur, Francesco Fachinetti, et al.
Biomedicines|September 28, 2023
Precision Medicine in Pancreatic Ductal Adenocarcinoma: The Impact of Targeted Therapies on Survival of Patients Harboring Actionable MutationsAnthony Tarabay, Alice Boileve, Cristina Smolenschi, et al.
Cancers|October 26, 2024
<i>KRAS</i>, a New Target for Precision Medicine in Colorectal Cancer?Alice Boilève, Cristina Smolenschi, Aurélien Lambert, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2025
Metastatic pancreatic adenocarcinoma: Real-world efficacy of first line treatmentMélanie Debiais, Anthony Tarabay, Sarah Blanchet-Deverly, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2026
Lung-only metastatic pancreatic cancer: Differences in patients 'characteristics, molecular profile and survivalAlice Boilève, Léa Mercier, Baptiste Bonnet, et al.
Future Oncology (London, England)|February 10, 2025
Predictive factors of FOLFIRINOX chemotherapy toxicity in pancreatic adenocarcinoma patientsRoland Eid, Anthony Tarabay, Pierre Decazes, et al.
International Journal of Cancer|August 15, 2024
Clinical and molecular features of early onset pancreatic adenocarcinomaMaxime Rémond, Cristina Smolenschi, Anthony Tarabay, et al.
European Journal of Cancer (Oxford, England : 1990)|November 9, 2025
Real-world immunotherapy outcomes in unresectable peritoneal mesothelioma: A French experienceCristina Smolenschi, Alice Boileve, Pauline Vaflard, et al.
Pageof 2